How artificial intelligence and data-driven systems can improve child protection services

BackgroundResearchers have increasingly adopted AI and next-generation sequencing (NGS), revolutionizing genomics and high-throughput screening (HTS), and transforming our understanding of cellular processes and disease mechanisms. However, these advancements generate vast datasets requiring effective data stewardship and curation practices to maintain data integrity, privacy, and accessibility. This review consolidates existing knowledge on key aspects, including data governance, quality management, privacy measures, ownership, access control, accountability, traceability, curation frameworks, and storage systems.MethodsWe conducted a systematic literature search up to January 10, 2024, across PubMed, MEDLINE, EMBASE, Scopus, and additional scholarly platforms to examine recent advances and challenges in managing the vast and complex datasets generated by these technologies. Our search strategy employed structured keyword queries focused on four key thematic areas: data governance and management, curation frameworks, algorithmic bias and fairness, and data storage, all within the context of AI applications in genomics and microscopy. Using a realist synthesis methodology, we integrated insights from diverse frameworks to explore the multifaceted challenges associated with data stewardship in these domains. Three independent reviewers, who systematically categorized the information across critical themes, including data governance, quality management, security, privacy, ownership, and access control conducted data extraction and analysis. The study also examined specific AI considerations, such as algorithmic bias, model explainability, and the application of advanced cryptographic techniques. The review process included six stages, starting with an extensive search across multiple research databases, resulting in 273 documents. Screening based on broad criteria, titles, abstracts, and full texts followed this, narrowing the pool to 38 highly relevant citations.ResultsOur findings indicated that significant research was conducted in 2023 by highlighting the increasing recognition of robust data governance frameworks in AI-driven genomics and microscopy. While 36 articles extensively discussed data interoperability and sharing, AI-model explain ability and data augmentation remained underexplored, indicating significant gaps. The integration of diverse data types—ranging from sequencing and clinical data to proteomic and imaging data—highlighted the complexity and expansive scope of AI applications in these fields. The current challenges identified in AI-based data stewardship and curation practices are lack of infrastructure and cost optimization, ethical and privacy considerations, access control and sharing mechanisms, large scale data handling and analysis and transparent data-sharing policies and practice. Proposed solutions to address issues related to data quality, privacy, and bias management include advanced cryptographic techniques, federated learning, and blockchain technology. Robust data governance measures, such as GA4GH standards, DUO versioning, and attribute-based access control, are essential for ensuring data integrity, security, and ethical use. The study also emphasized the critical role of Data Management Plans (DMPs), meticulous metadata curation, and advanced cryptographic techniques in mitigating risks related to data security and identifiability. Despite advancements, significant challenges persisted in balancing data ownership with research accessibility, integrating heterogeneous data sources, ensuring platform interoperability, and maintaining data quality. Ongoing risks of unauthorized access and data breaches underscored the need for continuous innovation in data management practices and stricter adherence to legal and ethical standards.ConclusionsThese findings explored the current practices and challenges in data stewardship, offering a roadmap for strengthening the governance, security, and ethical use of AI in genomics and microscopy. While robust governance frameworks and ethical practices have established a foundation for data integrity and transparency, there remains an urgent need for collaborative efforts to develop interoperable platforms and transparent data-sharing policies. Additionally, evolving legal and ethical frameworks will be crucial to addressing emerging challenges posed by AI technologies. Fostering transparency, accountability, and ethical responsibility within the research community will be key to ensuring trust and driving ethically sound scientific advancements.

Background: Parental mental health problems is a common source of concern reported to child welfare and protection services (CWPS). In this study we explored to what extent the child was invited to participate in the investigation process. We aimed to study: (a) what was the current practice in the child protection service in Norway when the CWPS received a report of concern about children whose parents were affected by mental health problems or substance abuse, (b) to what extent were children involved and consulted, (c) which factors predicted the decision to involve the children, and (d) in cases in which conversations with children were conducted: what was the main content of the conversations.Method: The study was a cross-sectional case file study (N = 1,123). Data were collected retrospectively from case records in 16 different child protection agencies. The cases were randomly drawn from all referrals registered in the participating agencies. Differences in how investigations were conducted in cases with and without concerns about parental mental health were analyzed using t-tests and chi-square testes. Predictors of child involvement in cases with parental mental health problems (N = 324) were estimated by logistic regression analyses.Results: When the referral to the CWPS contained concerns about parental mental health, there were more consultations with parents, more frequent home visits and the investigation took longer to conclude. The children, however, were less likely to be involved. Children in such cases were consulted in 47.5% of cases. Predictors for involving the children in those cases were child age, concern about the child's emotional problems and if the child was known from previous referrals.Conclusion: In Norwegian child protection investigations, in which there were concerns about the parent's mental health, conversations with children were conducted to a significantly lower degree compared to cases where the child's problem was the main concern. In such cases, the CWPS workers have to overcome a threshold before they consult with the child. The threshold decreases with child age and when case worker already knows the child.

Background: Nowadays, public health structure is very much disrupted with intensive communicable diseases like dengue, malaria or covid-19 and non-communicable disease like cancer. Identifying proper segment of population susceptible to disease gives us an overall idea of the disease outbreak and helps in taking some precautionary measure form the governance point of view of the regulatory authority. Accordingly, there is always a substantial impact of different socio-demographic features in public health specifically for communicable diseases. Materials & Method: A Decision Support System (DSS) can help us tracking and monitoring, in real-time, the variation of segmented population in a certain geographic dimension about who are already infected or susceptible to infection. And further studying and analyzing and predicting different socio-demographic parameters creates certain impact in the pandemic scenario. On top of that applying machine learning technique helps us to plan or impose awareness rules and regulations. Epidemiological Model are effective in predicting population infection ratio, considering some parameters as constant. Furthermore, data privacy and security is always a major concern while dealing with sensitive data in Decision Support System. Not only that a decision support system should be able to accept data from diversified sources and can able to store that in decentralized manner adopting multiple stakeholders with different roles and responsibilities. We have proposed a DSS comprises of epidemiological model, machine learning technique, blockchain technology and anonymization technique. This novel Decision Support System will not only act as an alarming mechanism on varying population, geographic dimension and demographic factors but also will show the overall impact of those factors in any pandemic scenario keeping decentralization and security measure intact. Conclusion: The study effectively validates the effectiveness of the proposed model and substantiate that it surpasses different existing competitors’ method as well. Keywords: Epidemiological model, Feedback-based SIR Model, Public Health, Blockchain, Anonymization

This paper explores aspects such as data privacy, algorithmic bias, and the potential risks of misinformation dissemination, highlighting the need for regulatory frameworks and ethical guidelines to regulate their applications. By synthesizing recent academic research and case studies, this paper comprehensively elaborates on the opportunities and challenges brought about by big data and artificial intelligence in communication research. Finally, a plan for future research is presented, emphasizing the need for interdisciplinary cooperation among computer science, media research, and ethics to reasonably tap the full potential of these technologies. It is suggested in the article that combining big data and artificial intelligence has made it much easier to guess what people will buy, which has huge implications for communication research and strategy development. However, ethical challenges like data privacy, algorithmic bias, and model transparency must be addressed to ensure sustainable and responsible application of these technologies. The research results highlight the significance of adopting a balanced approach, that is, maximizing innovation while adhering to ethical principles, ensuring that the integration of artificial intelligence and big data can actively promote the development of communication practices and social well - being.

The rapid enterprise adoption of Large Language Models (LLMs) has transformed knowledge work, decision support, and digital service delivery, yet their deployment introduces substantial risks related to data integrity, privacy exposure, algorithmic bias, hallucinated outputs, and unclear accountability across organizational boundaries. Traditional data governance and information security models were not designed to manage probabilistic, generative systems whose behaviors evolve dynamically with context, prompting the need for a new class of trustworthy AI governance mechanisms. This paper proposes a comprehensive Trustworthy AI and Data Governance Architecture that embeds integrity, ethics, and compliance controls directly into the lifecycle of enterprise LLM deployments, spanning data acquisition, model training, fine-tuning, retrieval augmentation, prompt orchestration, inference monitoring, and post-deployment auditing. The framework integrates policy-driven guardrails, lineage tracking, explainability checkpoints, human-in-the-loop oversight, and continuous risk evaluation to ensure traceability and responsible decision making. Control layers are aligned with emerging guidance from National Institute of Standards and Technology risk management principles and regulatory expectations established by the European Commission AI governance initiatives, enabling measurable assurance of fairness, reliability, and accountability. Through a design-science methodology and enterprise reference scenarios, the architecture demonstrates how organizations can operationalize ethical AI practices without sacrificing scalability or performance. The proposed model advances governance-by-design, transforming trust from an abstract principle into enforceable technical and procedural controls, thereby enabling safe, compliant, and sustainable LLM adoption across complex enterprise platforms.

Big Data, Big Expectations, and Big Judgements.

Multi-Agent-Based Decision Support Systems (MADSS) have emerged as powerful tools for facilitating decision-making in complex and dynamic environments. This chapter provides an overview of MADSS, highlighting their fundamental concepts, key components, and applications. MADSS leverage the principles of multi-agent systems, artificial intelligence, and decision support systems to enable collaborative decision-making among multiple autonomous agents. The chapter begins by introducing the concept of multi-agent systems, emphasizing the advantages they offer in terms of adaptability, flexibility, and scalability. It then explores the integration of decision support systems within this framework, enabling agents to make informed decisions by analyzing vast amounts of data, evaluating various alternatives, and considering multiple criteria. The architecture of MADSS is discussed, focusing on the interactions among agents, the coordination mechanisms employed, and the information exchange protocols utilized. Various agent types, such as user agents, decision agents, and knowledge agents, are described, along with their roles and responsibilities within the system. The chapter further explores the different approaches and techniques used in MADSS, including rule-based systems, expert systems, machine learning, and optimization algorithms. It highlights the importance of agent learning and adaptation to improve decision-making capabilities over time. The applications of MADSS across various domains are presented, including finance, supply chain management, healthcare, and transportation. Case studies illustrate how MADSS can enhance decision-making processes, improve efficiency, and optimize resource allocation in complex real-world scenarios. Lastly, the chapter discusses the challenges and future directions of MADSS. Issues such as agent coordination, trust among agents, and handling uncertainty are addressed. The potential of integrating emerging technologies like blockchain, the Internet of Things (IoT), and big data analytics is also explored, envisioning more sophisticated MADSS capable of handling larger-scale problems.

The intersection of big data and healthcare product development has catalyzed transformative shifts in the industry, revolutionizing how medical solutions are conceptualized, designed, and deployed. This theoretical and analytical review explores the profound impact of big data on healthcare product development, elucidating its implications across various facets of the healthcare landscape. Utilizing big data analytics, healthcare stakeholders can harness vast volumes of structured and unstructured data to derive actionable insights. These insights inform evidence-based decision-making processes, driving innovation in product development pipelines. By analyzing real-time patient data, trends, and treatment outcomes, developers gain invaluable insights into disease progression, treatment efficacy, and patient preferences, thus facilitating the creation of tailored, patient-centric solutions. Moreover, big data analytics play a pivotal role in improving patient outcomes and quality of care. Through predictive analytics and machine learning algorithms, healthcare providers can identify at-risk populations, predict disease outbreaks, and personalize treatment plans. This proactive approach enhances preventive care strategies and minimizes healthcare costs by averting complications and hospital readmissions. However, the integration of big data into healthcare product development is not without challenges. Data privacy and security concerns necessitate robust frameworks to safeguard sensitive patient information. Moreover, regulatory compliance frameworks must evolve to accommodate the complexities of big data analytics while ensuring patient safety and data integrity. Despite these challenges, the potential of big data in healthcare product development is vast. By leveraging big data analytics, stakeholders can bridge gaps in healthcare access and equity, tailor interventions to underserved populations, and optimize resource allocation. In conclusion, this review underscores the transformative impact of big data on healthcare product development. By embracing data-driven approaches, stakeholders can drive innovation, enhance patient outcomes, and navigate the evolving healthcare landscape with agility and efficacy. Keywords: Big Data, Healthcare Product Development, Innovation, Patient Outcomes, Data Analytics, Regulatory Compliance.

Artificial Intelligence (AI) and Big Data Analytics (BDA) are increasingly recognized as transformative forces that are reshaping industries, governance, and human society in profound ways. AI, with its foundations in machine learning, deep learning, natural language processing, and predictive modelling, requires vast amounts of data to train algorithms and generate reliable insights. Complementing this, BDA provides the scale, diversity, and velocity of data processing required to uncover hidden patterns, correlations, and trends within complex datasets. Together, AI and BDA form a synergistic paradigm in which Big Data serves as the fuel and AI operates as the engine, driving intelligent, data-driven innovation across multiple domains. Globally, AI-BDA applications are enabling predictive diagnostics, telemedicine platforms, genomic-driven personalized treatments, and advanced medical imaging, thereby enhancing both the accessibility and quality of care. In India, where the healthcare system must serve more than 1.4 billion citizens with limited resources, these technologies can play a pivotal role in addressing systemic challenges such as inadequate rural access, shortages of medical professionals, real-time disease surveillance, and hospital resource optimization. International best practices, including the NHS AI Lab in the United Kingdom, Mayo Clinic initiatives in the United States, and Ping a Good Doctor in China, provide models that India can adapt and scale to its unique demographic and infrastructural context. Despite their vast potential, the adoption of AI and BDA faces several barriers. Data privacy and cybersecurity remain critical concerns, particularly with the emergence of new regulations and the sensitive nature of health-related information. Additionally, algorithmic bias and the uneven availability of digital infrastructure could exacerbate existing inequities if not adequately addressed. Looking forward, advancements in Edge AI, Explainable AI (XAI), and quantum-enhanced analytics are expected to extend the scope and reliability of AI-BDA systems. This paper argues that the integration of AI and BDA is not merely a technological advancement but a paradigm shifts in how societies innovate, make decisions, and deliver essential services. Specifically, it highlights the need for a human-centric, ethical, and affordable approach to healthcare innovation in India in order to unlock the full transformative potential of these technologies. Keywords: Artificial Intelligence, Big Data Analytics, Healthcare Innovation, Predictive Diagnostics, Ethical AI, Edge AI.

The patient's medical data is very valuable and sensitive. Hackers are always trying to steal or tamper with this patient's data. Cyber-criminals can misuse or sell this patient's data. Protecting medical data, and ensuring security and privacy of data is a statutory and ethical mandate for healthcare services providers. Implementation of blockchain technology enhances the security, confidentiality, and traceability of patient data. Secure sharing of patient data among all stakeholders of healthcare ecosystems ensures quality and high speed in services.<br>Objective: This paper's objective is to review data security applications in the healthcare domain using blockchain technology and present the highlights from selected survey papers. The second objective is to implement data security using a web-based prototype based on blockchain technology. <br>Method: This blockchain technology enables secure online sharing of data using open, distributed, denationalized, and immutable ledgers. Blockchain-based online transactions are taking place between sender and receiver directly. Blockchain-based transactions eliminate the need for third-party intermediate agents. Data. Authors applied blockchain technology for the implementation of oral health big data using a web portal. Results: The taxonomy of concepts applied in blockchain and EHR, Smart Contracts, and Healthcare 4.0 systems in healthcare from the literature are mapped. To identify research gaps, a comparative study of curated survey papers is conducted with specific variables. The results of web portal implementation are discussed.<br>Conclusion: At the out, the authors tried to provide a holistic view of blockchain applications and presented insight into systems design by discussing algorithms, techniques and methods applied. Authors conclude that intelligent systems integrated blockchain systems are going to play a vital role in the healthcare industry and enhance the quality and efficiency of services.

Photo by Josh Riemer on Unsplash
 Introduction
 With the rapid advancements in neurotechnological machinery and improved analytical insights from machine learning in neuroscience, the availability of big brain data has increased tremendously. Neurological health research is done using digitized brain data.[1] There must be adequate data governance to secure the privacy of subjects participating in brain research and treatments. If not properly regulated, the research methods could lead to significant breaches of the subject’s autonomy and privacy. This paper will address the necessity for neuroprotection laws, which effectively govern the use of big brain data to ensure respect for patient privacy and autonomy.
 Background
 Artificial intelligence and machine learning can be integrated with neuroscience big brain data to drive research studies. This integrative technology allows patterns of electrical activity in neurons to be studied in detail.[2]Specifically, it uses a robotic system which can reason, plan, and exhibit biologically intelligent behavior. Machine learning is a method of computer programming where the code can adapt its behavior based on big brain data.[3] The big brain data is the collection of large amounts of information for the purpose of deciphering patterns through computer analysis using machine learning.[4] The information that these technologies provide is extensive enough to allow a researcher to read a patient’s mind. AI and machine learning technologies work by finding the underlying structure of brain data, which is then described by patterns known as latent factors, eventually resulting in an understanding of the brain’s temporal dynamics.[5]
 Through these technologies, researchers are able to decipher how the human brain computes its performances and thoughts. However, due to the extensive and complex nature of the data processed through AI and machine learning, researchers may gain access to personal information a patient may not wish to reveal. From a bioethical lens, tensions arise in the realm of patient autonomy. Patients are not able to control the transmission of data from their brains that is analyzed by researchers. Governing brain data through laws may enhance the extent of patient privacy in the case where brain data is being used through AI technologies.[6] A responsible approach to governing brain data would require a sophisticated legal structure.
 Analysis
 Impact on Patient Autonomy and Privacy 
 In research pertaining to big brain data, the consent forms do not fully cover the vast amounts of information that is collected. According to research, personal data has become the most sought out commodity to provide content to corporations and the web-based service industry. Unfortunately, data leaks that release private information frequently occur.[7] The storage of an individual’s data on technologies accessible on the internet during research studies makes it vulnerable to leaks, jeopardizing an individual’s privacy. These data leaks may cause the patient to be identified easily, as the degree of information provided by AI technologies are personalized and may be decoded through brain fingerprinting methods.[8]
 There has been an extensive growth in the development and use of AI. It is efficient in providing information to radiologists who diagnose various diseases including brain cancer and psychiatric disease, and AI assists in the delivery of telemedicine.[9] However, the ethical pitfall of reduced patient autonomy must be addressed by analyzing current AI technologies and creating more options for patient preference in how the data may be used. For instance, facial recognition technology[10] commonly used in health care produces more information than listed in common consent forms, threatening to undermine informed consent. Facial recognition software collects extensive data and may disclose more information than a person would prefer to provide despite being a useful tool for diagnosing medical and genetic conditions.[11] In addition, people may not be aware that their images are being used to generate more clinical data for other purposes. It is difficult to guarantee the data is anonymized. Consent requirements must include informing people about the complexity of the potential uses of the data; software developers should maximize patient privacy.[12] Furthermore, there is a “human element” in the use of AI technologies as medical providers control the use and the extent to which data is captured or accessed through the AI technologies.[13] People must understand the scope of the technology and have clear communication with the physician or health care provider about how the medical information will be used. 
 Existing Laws for Brain Data Governance 
 A strict system of defined legal responsibilities of medical providers will ensure a higher degree of patient privacy and autonomy when AI technologies and data from machine learning are used. Governing specific algorithmic data is crucial in safeguarding a patient’s privacy and developing a gold standard treatment protocol following the procurement of the information.[14] Certain AI technologies provide more data than others, and legal boundaries should be established to ensure strong performance, quality control, and scope for patient privacy and autonomy. For instance, currently AI technologies are being used in the realm of intensive neurological care. However, there is a significant level of patient uncertainty about how much control patients have over the data’s uses.[15] Calibrated legal and ethical standards will allow important brain data to be securely governed and monitored.
 Once brain signals are recorded and processed from one individual, the data may be merged with other data in Brain Computer Interface Technology (BCI).[16] To ensure a right and ability to retrieve personal data or pull it from the collection, specific regulations for varying types of data are needed.[17] The importance of consent and patient privacy must be considered through giving patients a transparent view of how brain data is governed.[18] The legal system must address discriminatory issues and risks to patients whose data is used in studies. Laws like the General Data Protection Regulation (GDPR) and the California Consumer Privacy Protection Act (CCPA) can serve as effective models to protect aggregated data. These laws govern consumer information and ensure the compliance when personal data is collected.[19] California voters recently approved expansion of the CCPA to health data. The Washington Privacy Act, which would have provided rights to access, change, and withdraw personal data, failed to pass. Other states should improve privacy as well,[20] although a federal bill would be preferable. Scientists at the Heidelberg Academy of Sciences argue for data security to be governed in a manner that balances patient privacy and autonomy with the commercial interests of researchers.[21] The balance could be achieved through privacy protections like those in the Washington Privacy Act. Although the Health Insurance Portability and Accountability Act (HIPAA) provides an overall framework to deter the likelihood of dangers to patient protection and privacy, more thorough laws are warranted to combat pervasive data transfer and analysis that technology has brought to the health care industry.[22] Breaches of patient privacy under current HIPAA regulations include releasing patient information to a reporter without their consent and sending HIV data to a patient’s employer without consent.[23] HIPAA does not cover information being shared with outside contractors who do not have an agreement with technology companies to keep patient data confidential. HIPAA regulations also do not always address blatant breaches on patient data confidentiality.[24] Patients must be provided with methods to monitor the data being analyzed to be able to view the extent of private information being generated via AI technologies. In health research, the medical purposes of better diagnosis, earlier detection of diseases, or prevention are ethical justifications for the use of the data if it was collected with permission, the person understood and approved the uses of the data, and the data was deidentified.
 A standard governance framework is required in providing the fairest system of care to patients who allow their brain data to be examined. Informed consent in the neuroscience field could reaffirm the privacy and autonomy of patients by ensuring that they understand the type of information collected. Laws also could protect data after a patient’s death. Malpractice in the scope of brain data could give people a cause of action critical in safeguarding patient’s rights. Data breach lawsuits will become common but generally do not cover deidentified data that becomes part of big data collection. A more synchronized approach to the collection and consent process will encourage an understanding of how big data is used to diagnose and treat patients. Some altruistic people may even be more likely to consent if they know the largescale data collection is helpful to treat and diagnose people. Others should have the ability to opt out of sharing neurological data, especially when there is not certainty surrounding deidentification.[25]
 Conclusion
 Artificial intelligence and machine learning technologies have the potential to aid in the diagnosis and treatment of people globally by extracting and aggregating brain data specific to individuals. However, the secure use of the data is necessary to build trust between care providers and patients, as well as in balancing the bioethical principles of beneficence and patient autonomy. We must ensure the highest quality of care to patients, while protecting their privacy, informed consent, and clinical trust. More sophis

This chapter provides an overview of the Irish child protection and welfare system, and examines continuities and discontinuities between the past and the present. 2012 is chosen as a pivotal change moment around which to critically examine current developments. This year is chosen due to seminal change events which occurred such as a referendum on the rights of the child and the publication of a report that led to the blueprint for the establishment of an independent Child and Family Agency in Ireland. We chart existing histories of child welfare and comment on significant trends and developments. Against the backdrop of this history, we discuss whether, almost 50 years on, the context, appetite for and investment in change, is to be realised in the biggest structural change to children’s services since the development of Community Care under the Health Act in 1970. In undertaking this analysis, we examine five themes: the establishment of a new Child and Family Agency (Tusla); Signs of Safety adopted as a new national child protection approach; changing trends in child welfare as demonstrated by recent statistics, retention rates for social workers in child protection; and dealing with retrospective child abuse disclosures, institutional abuse and Church-State relations.

The purpose of this study was to examine that how efficiency can be attain in Humanitarian Supply Chains Management (HSCM) through Enterprise Resource Planning (ERP), Block Chain Technology (BCT) and Big Data Analytics (BDA). A conceptual model is developed based on resource-based viewpoint and transactional cost theory that demonstrates the effects of BDA, Block Chain, and ERP on the performance of HSCM. The analysis shows that block chain connects people, groups, or nations to establish a network and plays a critical role in crisis management through monetary or non-monetary aid, whereas, BDA boosts the capacity of humanitarian operations to achieve their goals. Furthermore, it is also concluded that combining block chain with BDA capabilities can enhance HSCM performance. The study employed a quantitative approach, and responses from a 200-person sample size were gathered via survey questionnaires. Because Smart PLS, SEM enables broader dissemination in a variety of industries where non-normal data, small sample sizes, and formative indicators are being increased to support more complex model structures or solve data shortcomings like heterogeneity, the data was analyzed using this method. The PLS algorithm was used to analyze the study's data and content. The concept validity is tested using the Bootstrapping test, and the hypothesis outcomes are tested using binding folding. The findings (P-value P>0.05 and T-value 1.96 or higher) demonstrated that the study's premise had been amply confirmed by the current investigation. Due to its ability to narrow a performance gap between block chain and BDA in the current HSC literature and so improve the performance of the HSCM, this work is unique and valuable.

With the rapid development of Internet, artificial intelligence and big data, blockchain technology and credit technology came into being, and the mode of combining the blockchain and credit happens generally. However, this model is rarely involved in the field of medical insurance. In this article, it researches on the relationship of blockchain and credit technology, and the application of combining blockchain and credit technology in medical insurance in our county based on the retrospective, Tamper Proof, and decentralized characters of blockchain and the service of credit report, credit evaluation and Credit information consultation. It would solve the problems of incomplete and asymmetric information among medical institutions, patients, and medical insurance organizations, and also the problems of dishonesty in medical insurance.

The rapid advancement of digital technologies has transformed traditional governance models, paving the way for Smart Governance—a data-driven, technology-enabled approach that enhances transparency, efficiency, and public service delivery. The integration of Artificial Intelligence (AI), Internet of Things (IoT), Blockchain Technology, and Big Data Analytics has revolutionized urban management, ensuring real-time decision-making, optimized resource allocation, and improved citizen engagement. This paper explores the transformative potential of smart governance, focusing on its core technologies, implementation strategies, and associated challenges.